Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

XYLO-PFAN

XYLOSE

Standard Dose
25GM/BOT
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview XYLO-PFAN is listed in Drugs@FDA under application 017605 (NDA).

Marketing status: Discontinued Active ingredient XYLOSE Form and strength POWDER;ORAL - 25GM/BOT Sponsor SAVAGE LABS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview XYLO-PFAN is listed in Drugs@FDA under application 017605 (NDA). Marketing status: Discontinued Active ingredient XYLOSE Form and strength POWDER;ORAL - 25GM/BOT Sponsor SAVAGE LABS Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
XYLO-PFAN (XYLOSE) | Drug Monograph | MedicHelpline